EDITORIAL - Science versus myths: the case of COVID-19 vaccine hesitancy

Friday Okonofua(1), Rose Ugiagbe(2),

(1) Nigerian Academy of Science University of Benin
(2) University of Benin
Corresponding Author


The coronavirus disease 2019 (COVID-19), caused by a new strain of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-COV-2) was first reported to the World Health Organization (WHO) from the first case in Wuhan, China on December 31, 2019. The WHO declared the disease a pandemic on March 10, 2020 due to the fast pace of its progression throughout the world. Given the high number of deaths and severe socio-economic consequences associated with the disease, and because of the limited uptake of public health measures designed to prevent the spread of the virus, it became evident that only the discovery of a vaccine would help prevent the community spread of the virus. In May 2020, the 73rd World Health Assembly issued a resolution recognizing the role of extensive immunization as a global public-health goal for preventing the transmission of SARS-COV-2 (WHO, 2020). Consequently, several scientific groups in various parts of the world began to work on developing vaccines against the virus. The first vaccines were introduced in September 2020, and since then the WHO has approved seven vaccines for use against COVID-19. These include 1) Biotech BBV152 COVAXIN vaccine, 2) Sinova-coronavac COVID-19 vaccine, 3) Pfizer BioNTech (BN T162 b2) COVID-19 vaccine, 4) Sinopharm COVID-19 vaccine, 5) Janssen Ad26.cov2.S COVID-19 vaccine, 6) the Oxford/AstraZeneca COVID-19 vaccine, and 7) the Moderna COVID-19 (mRNA-1273) vaccine.


Science, Myths, Covid-19, Vaccine


Arede M, Bravo-Araya M, Bouchard E, Singh Gill G, Plajer V, Shehraj A, & Adam Shuaib Y (2019). Combating vaccine Hesitancy: Teaching the next generation to navigate through the post truth era. Front Public health 6: 381 doi 10.3389/fpubh.2018.00381.

Centers for Disease Control and Prevention. Reporting COVID-19 vaccinations in the United States. Cdc.gov/coronavirus/2019-ncov/vaccines/reporting-vaccinations.html.

Macdonald NE, SAGE Working group on vaccine Hesitancy. Vaccine hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine 2015: 33(34) 4161-4. Epub 2015 April 17.

Nigeria Centre for Disease Control. Reporting COVID-19 ncdc.gov.ng

Nugraha Rhea Veda et al. Traditional herbal medicine candidates as complementary treatments for COVID-19: Review of their mechanisms, Pros and Cons. Evidence-based Complementary and Alternative Medicine. 2020 Article ID25 60645 12 pages. https://doi.org/10.1155/2020/2560645.

Okunlola MA et al. Perceived myths and misconceptions about the novel COVID-19 outbreak. SciMedicine Journal, 2020: 2:3. Doi: 10.28991/SciMedJ-2020-0203-1.

Randolph HE, Barreiro LB. Herd immunity: understanding covid-19 immunity 2020: 52(5): 737-41

World Health Organization. COVID-19 response recognizing the role of extensive immunization. https://apps.who.int. >WHA73

World Health Organization. Update on omicron. WHO, Nov 28, 2021. Accessed from who.int/news./item/28-11-2021-update-on-omicron.

Full Text: PDF

Article Metrics

Abstract View : 146 times
PDF Download : 42 times

DOI: 10.57046/VZXV6019


  • There are currently no refbacks.

Copyright (c) 2022 Proceedings of the Nigerian Academy of Science

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.